ELANE and cancer: The CRC-bearing rats treated with PGPs-NE exhibited normalized metalloproteinase activity, stable biomarkers for cancer and inflammation, improved liver function, increased antioxidant levels, reduced levels of fragmented DNA, and PCNA expression.